START Los Angeles

START Los Angeles is a specialized clinical research site focused on Phase 1 oncology drug development. As part of the global South Texas Accelerated Research Therapeutics (START) network, the Los Angeles facility provides the infrastructure and expertise necessary to conduct complex early-phase clinical trials for biotechnology and pharmaceutical companies. The center offers patients access to innovative investigational treatments across various modalities, including targeted therapies and immunotherapies. By streamlining the transition from preclinical research to clinical application, START Los Angeles plays a critical role in accelerating the delivery of new cancer medicines to the market. The facility is staffed by experienced oncologists and research professionals dedicated to high-quality data collection and patient safety. Its strategic location in Los Angeles allows for collaboration with leading academic and medical institutions in the region.